Kelyniam Global, Inc. (KLYG)
USD 0.18
(-19.61%)
USD 0.18
(-19.61%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 217.61 Thousand USD | 88.95% |
| 2022 | 115.16 Thousand USD | 143.47% |
| 2021 | 47.3 Thousand USD | -69.74% |
| 2020 | 156.31 Thousand USD | -57.53% |
| 2019 | 368.06 Thousand USD | 67.94% |
| 2018 | 219.16 Thousand USD | 83.55% |
| 2017 | 119.4 Thousand USD | -22.36% |
| 2016 | 153.79 Thousand USD | -16.87% |
| 2015 | 185 Thousand USD | -20.3% |
| 2014 | 232.11 Thousand USD | -19.0% |
| 2013 | 286.54 Thousand USD | 0.0% |
| 2007 | 23.17 Thousand USD | -24.66% |
| 2006 | 30.76 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 210.36 Thousand USD | -1.72% |
| 2024 Q1 | 214.05 Thousand USD | -1.64% |
| 2023 Q4 | 217.61 Thousand USD | -1.56% |
| 2023 Q1 | 190.66 Thousand USD | 65.55% |
| 2023 Q3 | 221.05 Thousand USD | 17.63% |
| 2023 FY | 217.61 Thousand USD | 88.95% |
| 2023 Q2 | 187.92 Thousand USD | -1.44% |
| 2022 Q3 | 118.25 Thousand USD | 101.52% |
| 2022 Q1 | 22.07 Thousand USD | -53.33% |
| 2022 FY | 115.16 Thousand USD | 143.47% |
| 2022 Q4 | 115.16 Thousand USD | -2.61% |
| 2022 Q2 | 58.68 Thousand USD | 165.85% |
| 2021 Q2 | 138.8 Thousand USD | -52.42% |
| 2021 Q3 | 129.81 Thousand USD | -6.48% |
| 2021 Q4 | 47.3 Thousand USD | -63.56% |
| 2021 FY | 47.3 Thousand USD | -69.74% |
| 2021 Q1 | 291.75 Thousand USD | 86.65% |
| 2020 Q2 | 521.1 Thousand USD | 42.24% |
| 2020 FY | 156.31 Thousand USD | -57.53% |
| 2020 Q4 | 156.31 Thousand USD | -68.0% |
| 2020 Q3 | 488.46 Thousand USD | -6.26% |
| 2020 Q1 | 366.35 Thousand USD | -0.47% |
| 2019 FY | 368.06 Thousand USD | 67.94% |
| 2019 Q4 | 368.06 Thousand USD | -2.86% |
| 2019 Q3 | 378.91 Thousand USD | 43.91% |
| 2019 Q2 | 263.3 Thousand USD | 26.61% |
| 2019 Q1 | 207.95 Thousand USD | 0.0% |
| 2018 FY | 219.16 Thousand USD | 83.55% |
| 2017 FY | 119.4 Thousand USD | -22.36% |
| 2016 FY | 153.79 Thousand USD | -16.87% |
| 2015 FY | 185 Thousand USD | -20.3% |
| 2014 Q4 | 232.11 Thousand USD | -6.51% |
| 2014 FY | 232.11 Thousand USD | -19.0% |
| 2014 Q3 | 248.27 Thousand USD | 0.0% |
| 2014 Q1 | 272.47 Thousand USD | 0.0% |
| 2013 Q1 | 272.08 Thousand USD | 0.0% |
| 2013 FY | 286.54 Thousand USD | 0.0% |
| 2013 Q2 | 315.23 Thousand USD | 15.86% |
| 2008 Q1 | 21.22 Thousand USD | -8.41% |
| 2007 Q3 | 25.13 Thousand USD | -7.02% |
| 2007 FY | 23.17 Thousand USD | -24.66% |
| 2007 Q1 | 28.94 Thousand USD | 0.0% |
| 2007 Q4 | 23.17 Thousand USD | -7.79% |
| 2007 Q2 | 27.03 Thousand USD | -6.62% |
| 2006 FY | 30.76 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 12.52 Million USD | 98.263% |
| IR-Med Inc. | 161 Thousand USD | -35.162% |
| Polarean Imaging plc | 74.84 Thousand USD | -190.745% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -87.508% |
| Avitar, Inc. | 3.89 Million USD | 94.415% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 51.586% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | 99.93% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | 98.846% |
| Össur hf. | 311.8 Million USD | 99.93% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | 64.788% |
| Escalon Medical Corp. | 279.4 Thousand USD | 22.116% |
| Aurora Spine Corporation | 1.59 Million USD | 86.329% |
| BrainsWay Ltd. | 239 Thousand USD | 8.949% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 16.7 Million USD | 98.697% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | 99.973% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -398.239% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | 63.117% |
| Nanomix Corporation | 10.11 Million USD | 97.848% |
| Theraclion SA | 1.95 Million EUR | 88.845% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | 28.558% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -45.074% |
| Lombard Medical, Inc. | 28.02 Million USD | 99.224% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | 99.756% |
| Vycor Medical, Inc. | 243.28 Thousand USD | 10.554% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -52.893% |
| SANUWAVE Health, Inc. | 492 Thousand USD | 55.77% |
| VMS Rehab Systems, Inc. | 106.45 USD | -204325.552% |
| Guided Therapeutics, Inc. | 511 Thousand USD | 57.415% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | 59.117% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | 72.934% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | 32.503% |
| Urologix, Inc. | 4.58 Million USD | 95.255% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | 49.42% |
| Nexeon MedSystems Inc. | 2.78 Million USD | 92.19% |
| SS Innovations International, Inc. | 1.91 Million USD | 88.609% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 99.99% |
| NIOX Group Plc | 500 Thousand USD | 56.478% |
| Fuse Medical, Inc. | 200 Thousand USD | -8.806% |
| Broncus Holding Corporation | 1.22 Million USD | 82.221% |
| Brain Scientific Inc. | 7378.00 USD | -2849.458% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -34.441% |
| Health Logic Interactive Inc. | - USD | -Infinity% |